Cessation aids

This section of our site provides information on smoking cessation aids such as Nicotine Replacement Therapy (NRT), Zyban and Champix. See Smoking Cessation Update 2007: supplement to the 2004 smoking cessation guidleines for Scotland. A wider collection of resources are listed below in alphabetical order.

Search the NHS Scotland e-Library to look for more resources on smoking cessation aids.

	Bupropion Published on the Web by Patient UK, this document provides information on bupropion (also known as Zyban) which is a pharmaceutical aid for smoking cessation.
	Bupropion (zyban): a help to stop smoking Information leaflet on using bupropion (zyban) to stop smoking, covering side effects and listing those patients that zyban is not suitable for.
	Champix Produced by ASH Scotland in February 2007, this web page provides information about Champix. Champix is the trade name of a drug called varenicline. It is a non-nicotine based medicine designed to help people stop smoking.
	Champix patient information leaflet Patient information leaflet for Champix, designed for users
	Nicotine Replacement Therapy - NRT Published on the Web by Patient UK, this document provides information on nicotine replacement therapy as an aid for smoking cessation.
	NRT Produced by ASH Scotland this online leaflet provides information about NRT
	Prescribing of Smoking Cessation Interventions Scotland data on the prescribing of pharmaceutical interventions for smoking cessation in Scotland for the calendar years 2000 to 2008, inclusive. Statistics shown include prescribing volume, as measured by the number of prescribed items or defined daily dose, and the gross ingredient cost, at both Scotland and NHS board level.
	Smoking cessation guidelines for Scotland: 2004 update Jointly produced by NHS Health Scotland and ASH Scotland in November 2004. These guidelines make recommendations for the organisation and implementation of clinical interventions to promote smoking cessation in Scotland. Intended for use by health professionals and health planners at all levels.
	Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities Reducing the prevalence of smoking among people in routine and manual groups, some minority ethnic groups and disadvantaged communities will help reduce health inequalities more than any other measure to improve the public's health. Although NHS Stop Smoking Services have helped large numbers of people to quit smoking, smoking cessation rates are still lower among people in routine and manual groups compared with those in higher socioeconomic groups. In particular, pregnant women in routine and manual groups and those aged 20 or under may need additional support to give up smoking.
	Smoking cessation update 2007 This paper updates on guidance and recent developments since the Smoking Cessation Guidelines for Scotland: 2004 Update (NHS Health Scotland and ASH Scotland 2004). Developments that are expected to give guidance within the next year are also included.
	Stop smoking support in HM Prisons: the impact of nicotine replacement therapy. Executive summary and best practice checklist Funded by the Department of Health and authored by the Institute of Social Marketing, this document provides a summary and best practice checklist of a study which aimed to gather evidence and insight into the impact of nicotine replacement therapy in HM Prisons.
	The impact of DH funded provision of NRT in HM Prisons. Revised findings Funded by the Department of Health and authored by the Institute of Social Marketing, this study aimed to gather evidence and insight into the impact of this specially-funded nicotine replacement therapy.
	Zyban Produced by ASH Scotland this leaflet provides information about Zyban (bupropion).